Incidence and correlates of chlamydia trachomatis infection in a high-risk cohort of Kenyan women

Sexually Transmitted Diseases

Volumn 40, Issue 3, 2013, Pages 221-225

  Masese, Linnet ^a   Baeten, Jared M ^a   Richardson, Barbra A ^a,b   Deya, Ruth ^c   Kabare, Emmanuel ^c   Bukusi, Elizabeth ^a,c,d   John Stewart, Grace ^a   Jaoko, Walter ^c   Scott McClelland, R ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ABDOMINAL PAIN; ADULT; ARTICLE; CANDIDIASIS; CHLAMYDIASIS; COHORT ANALYSIS; DRUG USE; FEMALE; FOLLOW UP; GAS CHROMATOGRAPHY; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; KENYA; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; TRICHOMONIASIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INCIDENCE; KENYA; LONGITUDINAL STUDIES; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PUBLIC HEALTH; RISK FACTORS; SENTINEL SURVEILLANCE; SEX WORKERS; UNSAFE SEX; VAGINAL SMEARS;

EID: 84874063473     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e318272fe45     Document Type: Article

References (32)

1. WHO. Global prevalence and estimates of selected curable sexually transmitted infections: Overview and estimates, 2001. Available at: http://www.who.int/hiv/pub/sti/who-hiv-aids-2001.02.pdf. Accessed January 5, 2012.
2. Orroth KK, Korenromp EL, White RG, et al. Comparison of STD prevalences in the Mwanza, Rakai, and Masaka trial populations: The role of selection bias and diagnostic errors. Sex Transm Infect 2003; 79(2):98-105.
3. Pepin J, Deslandes S, Khonde N, et al. Low prevalence of cervical infections in women with vaginal discharge in west Africa: Implications for syndromic management. Sex Transm Infect 2004; 80(3):230-235.
4. Rassjo EB, Kambugu F, Tumwesigye MN, et al. Prevalence of sexually transmitted infections among adolescents in Kampala, Uganda, and theoretical models for improving syndromic management. J Adolesc Health 2006; 38(3):213-221.
5. Kaul R, Kimani J, Nagelkerke NJ, et al. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: A randomized controlled trial. Jama 2004; 291(21):2555-2562.
6. Sturm-Ramirez K, Brumblay H, Diop K, et al. Molecular epidemiology of genital Chlamydia trachomatis infection in high-risk women in Senegal, West Africa. J Clin Microbiol 2000; 38(1):138-145.
7. McClelland RS, Lavreys L, Katingima C, et al. Contribution of HIV-1 infection to acquisition of sexually transmitted disease: A 10-year prospective study. J Infect Dis 2005; 191(3):333-338.
8. van de Wijgert JH, Morrison CS, Brown J, et al. Disentangling contributions of reproductive tract infections to HIV acquisition in African Women. Sex Transm Dis 2009; 36(6):357-364.
9. Korenromp EL, Sudaryo MK, de Vlas SJ, et al. What proportion of episodes of Gonorrhoea and Chlamydia becomes symptomatic? Int J STD AIDS 2002; 13(2):91-101.
10. Batteiger BE, Xu F, Johnson RE, et al. Protective immunity to Chlamydia trachomatis genital infection: Evidence from human studies. J Infect Dis 2010; 201(suppl 2):S178YS189.
11. Kamenga MC, De Cock KM, St Louis ME, et al. The impact of human immunodeficiency virus infection on pelvic inflammatory disease: A case-control study in Abidjan, Ivory Coast. Am J Obstet Gynecol 1995; 172(3):919-925.
12. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study. AIDS 1993; 7(1):95-102.
13. WHO. Guidelines for the management of sexually transmitted infections, 2003. Available at: http://www.who.int/hiv/pub/sti/en/STIGuidelines2003. pdf. Accessed January 14, 2012.
14. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991; 29(2):297-301.
15. Baeten JM, Nyange PM, Richardson BA, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: Results from a prospective study. Am J Obstet Gynecol 2001; 185(2):380-385.
16. Datta SD, Sternberg M, Johnson RE, et al. Gonorrhea and Chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med 2007; 147(2):89-96.
17. Morrison CS, Bright P, Wong EL, et al. Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections. Sex Transm Dis 2004; 31(9):561-567.
18. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36(1):6-10.
19. Scott Lamontagne D, Baster K, Emmett L, et al. Incidence and reinfection rates of genital chlamydial infection among women aged 16-24 years attending general practice, family planning and genitourinary medicine clinics in England: A prospective cohort study by the Chlamydia Recall Study Advisory Group. Sex Transm Infect 2007; 83(4):292-303.
20. Walker J, Tabrizi SN, Fairley CK, et al. Chlamydia trachomatis incidence and re-infection among young womenVbehavioural and microbiological characteristics. PLoS One 2012; 7(5):e37778.
21. Brotman RM, Klebanoff MA, Nansel TR, et al. Bacterial vaginosis assessed by Gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis 2010; 202(12):1907-1915.
22. Kaul R, Nagelkerke NJ, Kimani J, et al. Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Infect Dis 2007; 196(11):1692-1697.
23. Critchlow CW, Wolner-Hanssen P, Eschenbach DA, et al. Determinants of cervical ectopia and of cervicitis: Age, oral contraception, specific cervical infection, smoking, and douching. Am J Obstet Gynecol 1995; 173(2):534-543.
24. Miller L, Patton DL, Meier A, et al. Depomedroxyprogesteroneinduced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol 2000; 96(3):431-439.
25. Heffron R, Donnell D, Rees H, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: A prospective cohort study. Lancet Infect Dis 2012; 12(1):19-26.
26. Peterman TA, Tian LH, Metcalf CA, et al. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: A case for rescreening. Ann Intern Med 2006; 145(8):564-572.
27. Gaydos CA, Quinn TC, Willis D, et al. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol 2003; 41(1):304-309.
28. McClelland RS, Richardson BA, Wanje GH, et al. Association between participant self-report and biological outcomes used to measure sexual risk behavior in human immunodeficiency virus-1Y seropositive female sex workers in Mombasa, Kenya. Sex Transm Dis 2011; 38(5):429-433.
29. Larsen U. Primary and secondary infertility in sub-Saharan Africa. Int J Epidemiol 2000; 29(2):285-291.
30. Gerrits T. Social and cultural aspects of infertility in Mozambique. Patient Educ Couns 1997; 31(1):39-48.
31. Omo-Aghoja LO, Okonofua FE, Onemu SO, et al. Association of Chlamydia trachomatis serology with tubal infertility in Nigerian women. J Obstet Gynaecol Res 2007; 33(5):688-695.
32. Siemer J, Theile O, Larbi Y, et al. Chlamydia trachomatis infection as a risk factor for infertility among women in Ghana, West Africa. Am J Trop Med Hyg 2008; 78(2):323-327.